A prospective, randomized study comparing standard dosing and genotype dosing of warfarin therapy

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-TRI-002
• By: LEE, Kyungeun (Chungbuk National University, College of Pharmacy, Cheongju-si, Korea, Republic Of)
• Co-author(s): Kyung Eun Lee: College of Pharmacy, Chungbuk National University, Cheongju-si, Korea, Republic Of
  Gwan Yung Lee: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
  Jee Eun Chung: College of Pharmacy, Sungkyunkwan University, Suwon-si, Korea, Republic Of
  Jeong Yee: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
  Hyun Jeong Kim: College of Pharmacy, Chungbuk National University, Cheongju-si, Korea, Republic Of
  Joo Hee Kim: College of Pharmacy, Ajou University, Suwon, Korea, Republic Of
  Hye Sun Gwak: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
  Byung Chul Chang: Department of Thoracic & Cardiovascular Surgery, Yonsei University Medical Center, Seoul, Korea, Republic Of
  
• Abstract:

  Background

  The level of anticoagulation in response to a fixed-dose regimen of warfarin is challenging. 

  Purpose

  We aimed to prospectively compare the effectiveness of genotype-based initial warfarin dosing with that of standard dosing in patients starting warfarin therapy.

  Methods

  We conducted a randomized, controlled trial involving patients with..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login